Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)
<p>Abstract</p> <p>Background</p> <p>Pap screening, an effective method for cervical cancer prevention, is now supported by molecular human papillomavirus (HPV) testing. Recently commercialised preventive vaccines also provide new tools for the primary prevention of cer...
Main Authors: | Orlando Giovanna, Tanzi Elisabetta, Chatenoud Liliane, Gramegna Maria, Rizzardini Giuliano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/204 |
Similar Items
-
Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS
by: Giovanna Orlando, et al.
Published: (2019-08-01) -
Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01) -
Comparison of HPV testing and cervical cytology in prevention of cervical cancer
by: Klaudia Remjasz, et al.
Published: (2022-08-01) -
HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania
by: Ursu Ramona, et al.
Published: (2011-12-01) -
Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context
by: Arianis Tatiana Ramírez, et al.
Published: (2023-10-01)